Form D · Pharmaceuticals
Goodsprout Co LLC
Fort Worth, TX · CIK 0001905406
Offering snapshot reported Nov 9, 2023 · SEC filing
- Reported sold
- $50K Indefinite offering
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Oct 31, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 9, 2023 | Initial | $50,000 | No comparison | 1 | SEC filing |
| Jan 19, 2022 | Initial | $600,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-496858
Source: Form D, filed Nov 9, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Neil Foster | Director |
| Chad Saltzman | Executive |
| Gaylord S. Van Guilder Ii | Director |
| Gaylord S. Van Guilder Iii | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2733 Cullen St.
Fort Worth, TX, 76107
Fort Worth, TX, 76107